Freshness vs Fragility 2025
- Sum of 2024 revenue from drugs approved 2020-2024
- Sum of 2024 revenue from drugs expiring 2024-2028
Which of these portfolios would you prefer to manage? More data here to remind us that in our industry there is no 'average pharma company'.
This data and more will be in the 2025 Pharmaceutical Innovation and Invention Index. The results launch on the 14th of May 2025.
Subscribe to our newsletter for more insights.
Further reading
-
Innovation
Identification and Predictive Analysis of Revenue Determinants in the Pharma Industry
Identification and Predictive Analysis of Revenue Determinants in the Pharma Industry: A Longitudinal Analysis of Financial, Regulatory and Pipeline Data
-
Announcement
Candel Therapeutics and IDEA Pharma Announce Strategic Partnership to Advance Path-to-Market Commercialization Efforts for CAN-2409
Candel Therapeutics and IDEA Pharma Announce Strategic Partnership to Advance Path-to-Market Commercialization Efforts for CAN-2409
